Diabetic foot ulcers

Lancet

Volumn 361, Issue 9368, 2003, Pages 1545-1551

  Jeffcoate, William J ^a   Harding, Keith G ^b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; ENZYME INHIBITOR; GENTAMICIN; IMIPENEM; LINEZOLID; METRONIDAZOLE; PENICILLINASE; QUINOLONE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; ERADICATION THERAPY; FOOT AMPUTATION; FOOT ULCER; HEALTH CARE; HEALTH SURVEY; HUMAN; INCIDENCE; INFECTION PREVENTION; ISCHEMIA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM; VASCULAR DISEASE; WOUND HEALING;

EID: 0037961580     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13169-8     Document Type: Review

References (133)

1. Kumar S., Ashe H.A., Parnell L.N., et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med. 11:1994;480-484.
2. Walters D.P., Gatling W., Mullee M.A., et al. The distribution and severity of diabetic foot disease: a community study with comparison to non-diabetic group. Diabet Med. 9:1992;354-358.
3. Reiber G.E., Lipsky B.A., Gibbons G.W. The burden of diabetic foot ulcers. Am J Surg. 176:1998;5S-10S.
4. Ramsey S.D., Newton K., Blough D., et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diab Care. 22:1999;382-387.
5. Henriksson F., Agardh C.-D., Berne C., et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med. 248:2000;387-396.
6. Muller I.S., de Grauw W.J.C., van Gerwen W.H.E.M., et al. Foot amputation and lower limb amputation in type 2 diabetic patients in Dutch primary health care. Diab Care. 25:2002;570-574.
7. Abbott C.A., Carrington A.L., Ashe H., et al. The NorthWest Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based cohort. Diabet Med. 19:2002;377-384.
8. Abbott C.A., Vileikyte L., Williamson S., et al. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diab Care. 21:1998;1071-1075.
9. Diabetes care and research in Europe: the Saint Vincent Declaration. Diabet Med. 7:1990;360.
10. Chaturvedi N., Stevens L.K., Fuller J.H., et al. Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes: the WHO multinational study of vascular disease in diabetes. Diabetologia. 44:(suppl 2):2001;S65-S71.
11. Oyibo S.O., Jude E.B., Tarawneh I., et al. The effects of ulcer size, patient's age, gender and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med. 18:2001;133-138.
12. Group T.G. Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia: the global lower extremity amputation study group. Br J Surg. 87:2000;328-337.
13. Apelqvist J., Larsson J., Agardh C.-D. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 233:1993;485-491.
14. Armstrong D.G., Lavery L.A., Harkless L.B. Validation of a diabetic wound classification system. Diab Care. 21:1998;855-859.
15. Van Houtum W.H., Lavery L.A. Outcomes associated with diabetes-related amputations in The Netherlands and in the state of California, USA. J Intern Med. 240:1996;227-231.
16. Van Houtum W.H., Lavery L.A., Harkless L.B. The impact of diabetes-related lower-extremity amputations in The Netherlands. J Diabetes Comp. 10:1996;325-330.
17. Witsø E., Rønningen H. Lower limb amputations: registration of all lower limb amputations performed at the University Hospital of Trondheim, Norway, 1994-1997. Prosthet Orthop Int. 25:2001;181-185.
18. Calle-Pascual A.L., Redondo M.J., Ballesteros M., et al. Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain. Diabets Metab. 23:1997;519-523.
19. Spichler E.R.S., Spichler D., Lessa I., et al. Capture-recapture method to estimate lower extremity amputation rates in Rio de Janeiro, Brazil. Pan Am J Public Health. 19:2001;334-340.
20. Trautner C., Giani G., Haastert B., et al. Unchanged incidence of lower-limb amputations in a German city, 1990-1998. Diab Care. 24:2001;855-859.
21. Wrobel J.S., Mayfield J.A., Reiber G.E. Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population. Diab Care. 24:2001;860-864.
22. Van Houtum W.H., Lavery L.A. Regional variation in the incidence of diabetes-related amputation in The Netherlands. Diabetes Res Clin Pract. 31:1996;125-132.
23. Canavan R., Connolly V., Airey C.M., et al. A population based study of lower extremity amputations among four UK centres. Diabet Med. 19:(suppl 2):2002;A23.
24. Chaturvedi N., Abbott C.A., Whalley A., et al. Risk of diabetes-related amputation in South Asians vs Europeans in the UK. Diabet Med. 19:2002;99-104.
25. Boyko E.J., Ahroni J.H., Smith D.G., et al. Increased mortality associated with diabetic foot ulcer. Diabet Med. 13:1996;967-972.
26. Moulik P., Gill G. Mortality in diabetic patients with foot ulcers. Diabet Foot. 5:2002;51-53.
27. Lavery L.A., van Houtum W.H., Harkless L.B. In-hospital mortality and disposition of the diabetic amputees in The Netherlands. Diabet Med. 13:1996;192-197.
28. da Silva A.F., Desgranges P., Holdsworth J., et al. The management and outcome of critical limb ischaemia in diabetic patients: results of a national survey. Audit Committee of the Vascular Surgical Society of Great Britain and Ireland. Diabet Med. 13:1996;726-728.
29. Faglia E., Favales F., Morabito A. New ulceration, new major amputation, and survival rats in diabetic subjects hospitalised for foot ulceration from 1990 to 1993: a 6·5 year follow-up. Diab Care. 24:2001;78-83.
30. Lee J.S., Lu M., Lee V.S., et al. Lower-extremity amputation: incidence, risk factors, and mortality in the Oklahoma Indian diabetes study. Diabetes. 42:1993;876-882.
31. Boulton A.J.M. The pathway to ulceration: aetiopathogenesis. Boulton A.J.M., Connor H., Cavanagh P.R. The foot in diabetes. 2000;19-31 John Wiley and Sons, Chichester.
32. Reiber G.E., Vileikyte L., Boyko E.J., et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diab Care. 22:1999;157-162.
33. Consensus Development Conference on Diabetic Foot Wound Care. Diab Care. 22:1999;1354-1360.
34. International Consensus on the Diabetic Foot. Amsterdam: International Working Group on the Diabetic Foot, 1999.
35. Adler E.I., Boyko E.J., Ahroni J.H., et al. Lower-extremity amputation in diabetes: the independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diab Care. 22:1999;1029-1035.
36. Macfarlane R.M., Jeffcoate W.J. Factors contributing to the presentation of diabetic foot ulcers. Diabet Med. 14:1997;867-870.
37. Greene D.A., Stevens M.J., Feldman E.L. Diabetic neuropathy: scope of the syndrome. Am J Med. 107:1999;2S-8S.
38. Vinik A.I. Diabetic neuropathy: pathogenesis and therapy. Am J Med. 107:1999;17S-26S.
39. Vinik A.I., Erbas T., Park T.S., et al. Dermal neurovascular dysfunction in type 2 diabetes. Diab Care. 24:2001;1468-1475.
40. Nabuurs-Franssen M.H., Houben A.J.H.M., Tooke J.E., Schaper N.C. The effect of polyneuropathy on foot microcirculation in type II diabetes. Diabetologia. 45:2002;1164-1171.
41. Jeffcoate W., Lima J., Nobrega L. The Charcot foot. Diabet Med. 17:2000;253-258.
42. Rajbandhari S.M., Jenkins R.C., Davies C., Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 45:2002;1085-1096.
43. Strandness D.E., Priest R.E., Gibbons G.E. Combined clinical and pathological study of diabetic and non diabetic peripheral arterial disease. Diabetes. 13:1964;366-372.
44. LoGerfo F.W., Coffman J.D. Vascular and microvascular disease of the foot in diabetes. N Engl J Med. 311:1984;1615-1619.
45. Akbari C.M., LoGerfo F.W. Diabetes and peripheral vascular disease. J Vasc Surg. 30:1999;373-384.
46. Chantelau E., Tanudjaja T., Altenhofer F., et al. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet Med. 13:1996;156-159.
47. Lipsky B.A., Berendt A.R. Principles and practice of antibiotic therapy of diabetic foot infections. Diabet Metab Res Rev. 16:(suppl):2000;42-46.
48. Lipsky B.A. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis. 25:1997;1318-1326.
49. Eckman M.H., Greenfield S., Mackey W.C., et al. Foot infections in diabetic patients. JAMA. 273:1995;712-720.
50. Hamilton A.I., Blackwood H.J. Insulin deficiency and cell proliferation in oral mucosal epitheliam of the rat. J Anat. 124:1977;757-763.
51. Yue D.K., Swanson B., McLellan S., et al. Abnormalities of granulation tissue and collagen formation in experimental diabetes, uraemia and malnutrition. Diabet Med. 3:1986;221-225.
52. Tengrup L., Hallmans G., Agren M.S. Granulation tissue formation and metabolism of zinc and copper in alloxan - diabetic rats. Sanc J Plast Reconstr Surg Hand Surg. 22:1998;41-45.
53. Delamaire M., Maugendre D., Moreno M., et al. Impaired leucocyte function in diabetic patients. Diabet Med. 14:1997;29-34.
54. Loots M.A., Lamme E.N., Zeegelgar J., et al. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous leg ulcers versus acute wounds. J Invest Dermatol. 111:1998;850-857.
55. Birke J.A., Novick A., Patout C.A., et al. Healing rates of plantar ulcers in leprosy and diabetes. Lepr Rev. 63:1992;365-374.
56. Jeffcoate W.J., Macfarlane R.M., Fletcher E.M. The description and classification of foot ulcers. Diabet Med. 10:1993;676-679.
57. Armstrong D.G., Peters E.J.G. Classification of wounds of the diabetic foot. Current Diab Reports. 1:2001;233-238.
58. Macfarlane R.M., Jeffcoate W.J. Classification of diabetic foot ulcers: the S(AD) SAD system. Diabet Foot. 2:1999;123-131.
59. Lipsky B.A. A current approach to diabetic foot infections. Curr Infect Dis Rep. 1:1999;253-260.
60. Tentolouris N., Jude E.B., Smirnof I., et al. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med. 16:1996;767-771.
61. Wagner A., Reike H., Angelkort B., et al. Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin-resistant Staphylococcus aureus infections. Dtsch Med Wochenschr. 126:2001;1353-1356.
62. Norden C.W. Acute and chronic osteomyelitis. Armstrong D., Cohen J. Infectious diseases. 1999;1-9 Mosby Wolfe ; 2, London.
63. Venkatesan P., Lawn S., Macfarlane R.M., et al. Conservative management of osetomyelitis in the feet of diabetic patients. Diabet Med. 14:1997;487-490.
64. Pittet D., Wyssa B., Herter-Clavel C., et al. Outcome of diabetic foot ulcerations treated conservatively: a retrospective cohort study with long-term follow-up. Arch Intern Med. 159:1999;851-856.
65. Embil J. The management of diabetic foot osteomyelitis. Diabet Foot. 3:2000;76-83.
66. McGee S.R., Boyko E.J. Physical examination, chronic lower-extremity ischemia: a critical review. Arch Intern Med. 158:1998;1357-1364.
67. Holstein P.E., Sorensen S. Limb salvage experience in a multidisciplinary diabetic foot clinic. Diab Care. 22:(suppl 2):1999;B97-B103.
68. Taylor R.S., Belli A.M., Jacob S. Distal venous arterialisation for salvage of critically ischaemic inoperable limbs. Lancet. 354:1999;1962-1965.
69. Akbari C.M., Pomposelli F.B. Jr, Gibbons G.W., et al. Lower extremity revascularisation in diabetes: late observations. Arch Surg. 135:2000;452-456.
70. Tunis S.R., Bass E.B., Steinberg E.P. The use of angioplasty, bypass surgery and amputation in the management of peripheral vascular disease. N Engl J Med. 325:1991;556-562.
71. Holstein P., Ellitsgaard N., Olsen B.B., et al. Decreasing incidence of major amputations in people with diabetes. Diabetologia. 43:2000;844-847.
72. Isaksson L., Lundgren F. Vein bypass surgery to the foot in patients with diabetes and critical ischaemia. Br J Surg. 81:1994;517-520.
73. Bradbury A.W., Ruckley C.V. Angioplasty for lower-limb ischaemia: time for randomised controlled trials. Lancet. 347:1996;277-278.
74. Cavanagh P.R., Ulbrecht J.S., Caputo G.M. What the practising physician should know about diabetic foot mechanics. Boulton A.J.M., Connor H., Cavanagh P.R. The foot in diabetes. 2000;33-59 John Wiley and Sons, Chichester.
75. Chantelau E., Haage P. An audit of cushioned diabetic footwear: relation to patient compliance. Diabet Med. 11:1994;114-116.
76. Armstrong D.G., Abu-Rumman P.L., Nixon B.P., et al. Continuous activity monitoring in persons at high risk for diabetes-related lower-extremity amputation. J Am Podiat Med Assoc. 9:2001;451-455.
77. Caravaggi C., Faglia E., De Giglio R., et al. Effectiveness and safety of a non-removable fibreglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomised study. Diab Care. 23:2000;1746-1751.
78. Armstrong D.G., Nguyen H.C., Lavery L.A., et al. Off-loading the diabetic foot wound. Diab Care. 24:2001;1019-1022.
79. Falanga V. Classification for wound bed preparation of chronic wounds. Wound Rep Regen. 8:2000;347-352.
80. Bradley M, Cullum N, Sheldon T. The debridement of chronic wounds: a systematic review. Health Technol Assess 1999; 3: no 17, part 1.
81. Blume P.A., Paragas L.K., Sumpio B.E., et al. Single-stage surgical treatment of noninfected diabetic foot ulcers. Plast Reconstr Surg. 109:2002;601-609.
82. Piaggesi A., Schipani E., Campi F., et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomised trial. Diabet Med. 15:1998;412-417.
83. O'Meara S, Cullum, N, Majid M, Sheldon T. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. Health Technol Assess 2000; 4: no 21.
84. Mumcuoglu K.Y. Clinical applications for maggots in wound care. Am J Clin Dermatol. 2:2000;219-227.
85. Mason J., O'Keffe C., Hutchinson A., et al. A systematic review of foot ulcer in patients with type 2 diabetes mellitus: II - treatment. Diabet Med. 16:1999;889-909.
86. Armstrong D.G., Nguyen H.C. Improvement in healing with aggressive edema reduction after debridement of foot infection in persons with diabetes. Arch Surg. 135:2000;1405-1409.
87. Harding K.G., Morris H.L., Patel G.K. Healing chronic wounds. BMJ. 324:2002;160-163.
88. De P., Scarpello J.H.B. What is the evidence for effective treatment of diabetic foot ulceration? Pract Diabetes Int. 16:1999;179-184.
89. Bradley M, Cullum N, Nelson EA, et al. Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds. Health Technol Assess 1999; 3: no 17, part 2.
90. Harding K.G., Jones V.J., Price P. Topical treatment: which dressing to choose. Diabet Metab Res Rev. 16:(suppl 1):2000;547-550.
91. Harding K., Cutting K., Price P. The cost-effectiveness of wound management protocols of care. Brit J Nurs. 19:2000;S6-S24.
92. Cooper D.M., Yu E. Z., Hennesey P., et al. Determination of endogonous cytokines in chronic wounds. Ann Surg. 219:1994;668-692.
93. Ross R. Platelet-derived growth factor. Lancet. 1:1989;1179-1182.
94. Margolis D. J., Kantor J., Santanna J., et al. Effectiveness of platelet releasate for the treatment of diabetic neuropathic fott ulcers. Diab Care. 24:2001;483-488.
95. Steed D.L. Clinical evaluation of recombinant human platelet derived growth factors for the treatment of lower extremity diabetic ulcers. J Vasc Surg. 21:1995;71-81.
96. Wieman T.J., Smiell J.M., Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet derived growth factor BB (Becaplermin) in platelets with chronic neuropathic diabetic foot ulcers: a phase III randomised placebo controlled double blind study. Diab Care. 21:1998;822-827.
97. Gough A., Clapperton M., Rolando N., et al. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot ulceration. Lancet. 350:1997;855-859.
98. de Lalla F., Pellizer G., Strazzabosco M., et al. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother. 45:2000;1094-1098.
99. Yonem A., Cakir B., Guler S., et al. Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection. Diabetes Obes Metab. 3:2001;332-337.
100. Martin T., Harding K.G., Jiang W.G. Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts. Angiogenesis. 3:1999;69-76.
101. Pollak R.A., Edington H., Jensen J.L., et al. A human dermal replacement for the treatment of diabetic foot ulcers. Wounds. 9:1997;175-183.
102. Veves A., Flanaga V., Armstrong D.G., et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomised multicenter trial. Diab Care. 24:2001;290-295.
103. Allenet B., Paree F., Lebrun T., et al. Cost-effectiveness modelling of Dermagraft for the treatment of diabetic foot ulcers in the French context. Diabet Metab. 26:2000;125-132.
104. Ragnarsson Tennvall G., Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia. 44:2001;2077-2081.
105. Patout C.A., Birke J.A., Horswell R., et al. Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. Diab Care. 23:2000;1339-1342.
106. Rith-Najarian S., Branchard C., Beaulieu O., et al. Reducing lower-extremity amputations due to diabetes: application of the staged diabetes management approach in a primary care setting. J Fam Pract. 47:1998;127-132.
107. Mayfield J.A., Reiber G.E., Nelson R.G., et al. Do foot examinations reduce the risk of diabetic amputation? J Fam Pract. 49:2000;505-506.
108. Bruckner M., Mangan M., Godin S., et al. Project LEAP of New Jersey: lower extremity amputation prevention in persons with type 2 diabetes. Am J Manag Care. 5:1999;609-616.
109. Valk G.D., Kriegsman D.M.W., Assendelft W.J. Patient education for preventing diabetic foot ulceration: a systematic review. Endocrinol Metab Clin N Am. 31:2002;633-658.
110. Litzelman D.K., Marriott D.J., Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diab Care. 20:1997;1273-1278.
111. Reiber G.E., Smith D.G., Wallace C., et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomised controlled trial. JAMA. 287:2002;2552-2558.
112. Barth R., Campbell L.V., Allen S., et al. Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes. Diabet Med. 8:1991;111-117.
113. Malone J.M., Snyder M., Anderson G., et al. Prevention of amputation by diabetic education. Am J Surg. 158:1989;520-524.
114. McCabe C.J., Stevenson R.C., Dolan A.M. Evaluation of a diabetic foot screening and protection programme. Diabet Med. 15:1998;80-84.
115. Valk G.D., Kriegsman D.M., Assendelft W.J. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev. 4:2001;CD001488.
116. Larsson J., Apelqvist J., Agardh C.-D., et al. Decreasing incidence of lower limb amputations in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med. 12:1995;770-776.
117. Calle-Pascual AL, Garcia-Torre N, Moraga I, et al. Epidemiology of nontraumatic lower-extremity amputations in Area 7, Madrid, between 1989 and 1999. Diab Care 24: 1686-89.
118. Faglia E., Favales F., Aldeghi A., et al. Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation. J Diabet Comp. 12:1998;96-102.
119. Trautner C., Haastert B., Spraul M., et al. Unchanged incidence of lower-limb amputation in a German City 1990-1998. Diab Care. 24:2001;855-859.
120. Mayfield J.A., Reiber G.E., Maynard C., et al. Trends in lower limb amputation in the Veterans Health Administration, 1989-1998. J Rehab Res Devel. 37:2000;23-30.
121. Stiegler H., Standl E., Frank S., et al. Failure of reducing lower extremity amputations in diabetic patients: results of two subsequent population based surveys 1990 and 1995 in Germany. Vasa. 27:1998;10-14.
122. Feinglass J, Brown JL, LoSasso A, et al. Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996.
123. Anon. Hospital discharge rates for nontraumatic lower extremity amputation by diabetes status - United States, 1997. MMWR Morb Mortal Wkly Rep 2001; 50: 954-58.
124. Tennvall G.R., Apelqvist J., Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics. 18:2000;225-238.
125. Margolis D.J., Kantor J., Berlin J.A. Healing of diabetic neuropathic foot ulcers receiving standard treatment: a meta-analysis. Diab Care. 22:1999;692-695.
126. Vileikyte L. Diabetic foot ulcers: a quality of life issue. Diabetes Metab Res Rev. 17:2001;246-249.
127. Meijer J.W., Trip J., Jaegers S.M., et al. Quality of life in patients with diabetic foot ulcers. Disabil Rehabil. 20:2001;336-340.
128. Ragnarsson Tennvall G., Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabet Compl. 14:2000;235-241.
129. Carrington A.L., Mawdsley S.K., Morley M., et al. Psychological status of diabetic people with or without lower limb disability. Diabetes Res Clin Pract. 32:1996;19-25.
130. Abetz L., Sutton M., Brady L., McNulty P., Gagnon D.D. The diabetic foot ulcer scale (DFS): a quality of life instrument for use in clinical trials. Pract Diab Int. 19:2002;167-175.
131. Harrington C., Zagari M.J., Corea J., et al. A cost analysis of diabetic lower-extremity ulcers. Diab Care. 23:2000;1333-1338.
132. Steed D.L., Edington H., Mossa H.H., et al. Organisation and development of a university multidisciplinary wound care clinic. Surgery. 114:1993;775-779.
133. Gottrup F., Holstein P., Jørgensen B., Lohmann M., Karlsmar T. A new concept of a multidisciplinary wound healing center and a national expert function of wound healing. Arch Surg. 136:2001;765-772.